PAROXETINE

PAROXETINE was reported 41745 times

PAROXETINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COGWHEEL RIGIDITY 84 0.0800
1 NEONATAL BEHAVIOURAL SYNDROME 24 0.0784
2 CONGENITAL HYDROCEPHALUS 36 0.0710
3 GASTRIC PH DECREASED 50 0.0488
4 SEROTONIN SYNDROME 932 0.0485
5 GRANULOMA SKIN 38 0.0463
6 DEREALISATION 97 0.0451
7 RESTING TREMOR 28 0.0433
8 AGORAPHOBIA 58 0.0424
9 POISONING DELIBERATE 400 0.0421
10 ANTICHOLINERGIC SYNDROME 66 0.0414
11 SOCIAL ANXIETY DISORDER 26 0.0396
12 H1N1 INFLUENZA 50 0.0356
13 HOMICIDE 64 0.0347
14 HALLUCINATIONS, MIXED 146 0.0347
15 CLONUS 93 0.0340
16 SOPOR 449 0.0339
17 PARASOMNIA 24 0.0334
18 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 62 0.0314
19 PRESCRIPTION FORM TAMPERING 24 0.0311
20 VICTIM OF CRIME 38 0.0307
21 TEARFULNESS 131 0.0304
22 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 26 0.0292
23 LABELLED DRUG-DRUG INTERACTION ISSUE 41 0.0283
24 BEZOAR 39 0.0283
25 HYPOCOAGULABLE STATE 26 0.0267
26 BLOOD PARATHYROID HORMONE DECREASED 38 0.0256
27 HYPERREFLEXIA 88 0.0252
28 EMOTIONAL POVERTY 43 0.0245
29 FEELING OF DESPAIR 113 0.0242
30 ACCIDENTAL POISONING 33 0.0241
31 HEAD TITUBATION 33 0.0240
32 HAEMATOMA MUSCLE 28 0.0234
33 ANORGASMIA 62 0.0228
34 ALCOHOL INTERACTION 44 0.0226
35 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 24 0.0226
36 FLAT AFFECT 51 0.0220
37 HYPERPARATHYROIDISM SECONDARY 54 0.0215
38 CHOREA 37 0.0215
39 NEUROLEPTIC MALIGNANT SYNDROME 251 0.0211
40 BRADYPHRENIA 138 0.0211
41 GENERALISED ANXIETY DISORDER 31 0.0211
42 MYDRIASIS 259 0.0202
43 DISORGANISED SPEECH 36 0.0195
44 SEDATION COMPLICATION 49 0.0192
45 REBOUND ACID HYPERSECRETION 58 0.0192
46 APRAXIA 28 0.0189
47 ACCIDENTAL DEATH 35 0.0188
48 ALCOHOL ABUSE 50 0.0187
49 HYPOMANIA 68 0.0185
50 TONIC CLONIC MOVEMENTS 24 0.0184
51 CEREBRAL HAEMATOMA 62 0.0184
52 NEPHROGENIC ANAEMIA 84 0.0181
53 DRUG TOLERANCE DECREASED 50 0.0178
54 PANNICULITIS 43 0.0178
55 INTENTIONAL SELF-INJURY 340 0.0168
56 BLEPHAROSPASM 104 0.0165
57 NEUROLOGICAL DECOMPENSATION 38 0.0164
58 ILLUSION 27 0.0163
59 VASOPLEGIA SYNDROME 26 0.0158
60 BRADYKINESIA 93 0.0157
61 DRUG ABUSE 1299 0.0156
62 DISINHIBITION 25 0.0155
63 PSYCHIATRIC DECOMPENSATION 30 0.0153
64 BRADYPNOEA 41 0.0152
65 LOSS OF LIBIDO 131 0.0146
66 ANTIPSYCHOTIC DRUG LEVEL INCREASED 41 0.0145
67 RHEUMATOID NODULE 40 0.0145
68 BREATH SOUNDS ABNORMAL 71 0.0144
69 DISSOCIATION 110 0.0143
70 RESPIRATORY ACIDOSIS 56 0.0142
71 HYPERSEXUALITY 26 0.0142
72 PERSONALITY DISORDER 37 0.0141
73 HYPERTONIA 80 0.0140
74 MUSCLE RIGIDITY 161 0.0134
75 DEPRESSIVE SYMPTOM 47 0.0133
76 LIBIDO INCREASED 27 0.0133
77 ELECTRIC SHOCK SENSATION 37 0.0132
78 PSYCHOMOTOR RETARDATION 37 0.0132
79 SUBSTANCE USE DISORDER 41 0.0129
80 HALLUCINATION, AUDITORY 204 0.0128
81 HYPERTHERMIA 98 0.0128
82 IMPULSIVE BEHAVIOUR 48 0.0128
83 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 131 0.0127
84 POISONING 160 0.0127
85 SELF-INJURIOUS IDEATION 53 0.0126
86 HOSTILITY 32 0.0126
87 MANIA 206 0.0125
88 POTENTIATING DRUG INTERACTION 42 0.0125
89 DRUG USE DISORDER 105 0.0125
90 CLEFT PALATE 24 0.0124
91 HEPATIC CYTOLYSIS 155 0.0121
92 SUICIDE ATTEMPT 735 0.0121
93 DRUG INTERACTION 1913 0.0120
94 WITHDRAWAL SYNDROME 503 0.0120
95 EXPOSURE VIA INGESTION 30 0.0119
96 COMPLETED SUICIDE 987 0.0118
97 COLITIS MICROSCOPIC 56 0.0118
98 MYOCLONUS 141 0.0118
99 HAEMORRHAGIC DIATHESIS 42 0.0118
100 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 26 0.0116
101 YAWNING 31 0.0116
102 TALIPES 36 0.0116
103 ATRIAL SEPTAL DEFECT 97 0.0116
104 BLOOD PRESSURE DIASTOLIC ABNORMAL 29 0.0114
105 WOUND COMPLICATION 39 0.0114
106 FEELING OF BODY TEMPERATURE CHANGE 66 0.0112
107 ACUTE PULMONARY OEDEMA 63 0.0112
108 PANIC ATTACK 409 0.0112
109 AGITATION 824 0.0112
110 OCULOGYRIC CRISIS 24 0.0112
111 SELF ESTEEM DECREASED 27 0.0111
112 VENTRICULAR SEPTAL DEFECT 63 0.0110
113 COMA 521 0.0109
114 HYPONATRAEMIA 615 0.0109
115 SUSPECTED SUICIDE 51 0.0109
116 THERAPEUTIC PRODUCT INEFFECTIVE 42 0.0109
117 PARKINSONISM 105 0.0108
118 RHEUMATOID FACTOR POSITIVE 62 0.0107
119 TACHYPHRENIA 37 0.0107
120 SMALL FOR DATES BABY 52 0.0105
121 ALCOHOL POISONING 28 0.0104
122 DELIRIUM 360 0.0104
123 SUICIDAL BEHAVIOUR 43 0.0103
124 PREMATURE LABOUR 58 0.0102
125 SINUS TACHYCARDIA 145 0.0102
126 SENSORY LOSS 82 0.0102
127 ANXIETY DISORDER 34 0.0102
128 SEXUAL DYSFUNCTION 118 0.0101
129 ALCOHOLISM 43 0.0100
130 ASPHYXIA 82 0.0100
131 HALLUCINATION, VISUAL 211 0.0100
132 SUICIDAL IDEATION 913 0.0100
133 COMPARTMENT SYNDROME 26 0.0100
134 INTENTIONAL OVERDOSE 632 0.0098
135 ALTERED STATE OF CONSCIOUSNESS 213 0.0098
136 EXTRAPYRAMIDAL DISORDER 244 0.0098
137 ELECTROENCEPHALOGRAM ABNORMAL 31 0.0098
138 TOXICITY TO VARIOUS AGENTS 1649 0.0098
139 NIGHTMARE 338 0.0098
140 AKATHISIA 133 0.0097
141 SUBSTANCE ABUSE 79 0.0097
142 RESPIRATORY DEPRESSION 117 0.0095
143 DRUG LEVEL INCREASED 158 0.0095
144 BEHAVIOUR DISORDER 51 0.0094
145 DROOLING 65 0.0094
146 AGGRESSION 470 0.0094
147 HYPERPROLACTINAEMIA 60 0.0092
148 POSTURE ABNORMAL 30 0.0092
149 MAJOR DEPRESSION 67 0.0092
150 VITAMIN B12 DEFICIENCY 37 0.0091
151 HANGOVER 32 0.0091
152 OBSESSIVE-COMPULSIVE DISORDER 73 0.0091
153 MIOSIS 73 0.0091
154 DISORIENTATION 360 0.0091
155 ELECTROCARDIOGRAM QT PROLONGED 324 0.0090
156 NEGATIVE THOUGHTS 26 0.0089
157 HYPERACUSIS 33 0.0089
158 ENCEPHALOPATHY 216 0.0088
159 BUNDLE BRANCH BLOCK LEFT 37 0.0087
160 TENSION 53 0.0087
161 HAEMORRHAGIC STROKE 67 0.0086
162 DISTURBANCE IN ATTENTION 461 0.0085
163 PANIC DISORDER 33 0.0085
164 MUSCLE DISORDER 69 0.0085
165 DYSTONIA 165 0.0085
166 RESTLESSNESS 311 0.0085
167 SKIN NECROSIS 44 0.0085
168 SWOLLEN JOINT COUNT INCREASED 27 0.0085
169 HEPATOCELLULAR INJURY 120 0.0085
170 DYSKINESIA 336 0.0083
171 LOGORRHOEA 29 0.0082
172 AFFECT LABILITY 79 0.0082
173 CARDIOPULMONARY FAILURE 32 0.0082
174 HEART DISEASE CONGENITAL 29 0.0082
175 TORSADE DE POINTES 64 0.0081
176 DECREASED INTEREST 48 0.0081
177 MULTIPLE DRUG OVERDOSE INTENTIONAL 26 0.0081
178 PAROSMIA 61 0.0081
179 PATENT DUCTUS ARTERIOSUS 32 0.0081
180 CONFUSIONAL STATE 1295 0.0080
181 RESTLESS LEGS SYNDROME 145 0.0080
182 COMA SCALE ABNORMAL 23 0.0079
183 NEONATAL RESPIRATORY DISTRESS SYNDROME 28 0.0079
184 CATATONIA 41 0.0078
185 LEFT VENTRICULAR DYSFUNCTION 52 0.0078
186 MOTOR DYSFUNCTION 79 0.0077
187 ERECTILE DYSFUNCTION 199 0.0077
188 HOMICIDAL IDEATION 31 0.0076
189 HYPERNATRAEMIA 38 0.0076
190 PARADOXICAL DRUG REACTION 28 0.0076
191 MOOD SWINGS 242 0.0076
192 CEREBRAL ATROPHY 30 0.0075
193 AFFECTIVE DISORDER 59 0.0075
194 SEDATION 195 0.0074
195 INCOHERENT 48 0.0074
196 SCHIZOPHRENIA 90 0.0074
197 INCONTINENCE 78 0.0074
198 TRISMUS 38 0.0074
199 OBESITY 117 0.0073
200 THERMAL BURN 52 0.0073
201 TOXIC ENCEPHALOPATHY 37 0.0073
202 DELUSION 113 0.0073
203 MENSTRUAL DISORDER 60 0.0072
204 RHABDOMYOLYSIS 302 0.0072
205 RED BLOOD CELL SEDIMENTATION RATE INCREASED 80 0.0072
206 PSYCHOTIC DISORDER 213 0.0072
207 CHOLESTASIS 136 0.0071
208 FACET JOINT SYNDROME 23 0.0071
209 APATHY 103 0.0071
210 GASTRIC INFECTION 27 0.0071
211 PIGMENTATION DISORDER 43 0.0070
212 RHEUMATIC FEVER 31 0.0069
213 OLIGURIA 43 0.0069
214 PARANOIA 118 0.0068
215 MUSCLE CONTRACTIONS INVOLUNTARY 24 0.0068
216 EYE MOVEMENT DISORDER 46 0.0067
217 METABOLIC DISORDER 39 0.0067
218 SUBDURAL HAEMATOMA 96 0.0067
219 CARDIO-RESPIRATORY ARREST 280 0.0067
220 ON AND OFF PHENOMENON 37 0.0067
221 RENAL TUBULAR NECROSIS 65 0.0066
222 HYPOKINESIA 95 0.0065
223 THYROID MASS 25 0.0065
224 GESTATIONAL DIABETES 31 0.0065
225 PSYCHIATRIC SYMPTOM 48 0.0065
226 COGNITIVE DISORDER 303 0.0065
227 FREEZING PHENOMENON 24 0.0065
228 DEPRESSED MOOD 342 0.0065
229 CHRONIC KIDNEY DISEASE 491 0.0065
230 SLEEP DISORDER 455 0.0064
231 HYPOTHERMIA 65 0.0064
232 SOCIAL AVOIDANT BEHAVIOUR 37 0.0064
233 SHOCK HAEMORRHAGIC 52 0.0064
234 END STAGE RENAL DISEASE 116 0.0064
235 DRUG WITHDRAWAL SYNDROME 557 0.0063
236 CONGENITAL ANOMALY 49 0.0063
237 URINARY RETENTION 211 0.0063
238 MENTAL STATUS CHANGES 175 0.0063
239 CYANOSIS 99 0.0063
240 SOMNOLENCE 1260 0.0063
241 GALACTORRHOEA 40 0.0062
242 DEPRESSED LEVEL OF CONSCIOUSNESS 246 0.0062
243 HEPATIC ENCEPHALOPATHY 58 0.0062
244 APHASIA 187 0.0062
245 STRESS CARDIOMYOPATHY 36 0.0062
246 HEPATITIS ACUTE 40 0.0061
247 ANHEDONIA 161 0.0061
248 FOETAL EXPOSURE DURING PREGNANCY 498 0.0061
249 ATAXIA 72 0.0061
250 ORTHOSTATIC HYPOTENSION 105 0.0060
251 NYSTAGMUS 32 0.0060
252 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
253 POST-TRAUMATIC STRESS DISORDER 40 0.0060
254 IRON DEFICIENCY ANAEMIA 55 0.0060
255 BRADYCARDIA 316 0.0060
256 ABNORMAL DREAMS 164 0.0059
257 ASPIRATION 65 0.0059
258 BRUXISM 32 0.0059
259 DYSARTHRIA 223 0.0059
260 BLOOD LACTIC ACID INCREASED 31 0.0059
261 EMOTIONAL DISORDER 181 0.0059
262 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 36 0.0058
263 TREMOR 966 0.0058
264 PNEUMONIA ASPIRATION 145 0.0058
265 DRUG-INDUCED LIVER INJURY 182 0.0058
266 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
267 HYPERHIDROSIS 740 0.0057
268 THINKING ABNORMAL 107 0.0057
269 ANGER 194 0.0057
270 ELECTROCARDIOGRAM ABNORMAL 45 0.0057
271 BLEPHARITIS 23 0.0057
272 HYPOTONIA 57 0.0057
273 DIZZINESS POSTURAL 55 0.0057
274 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 50 0.0056
275 INTERVERTEBRAL DISC DISORDER 24 0.0056
276 SYNOVITIS 101 0.0056
277 CORONARY ARTERY STENOSIS 28 0.0056
278 GENERALISED TONIC-CLONIC SEIZURE 92 0.0056
279 TACHYCARDIA 492 0.0055
280 EXOSTOSIS 50 0.0055
281 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
282 IRRITABILITY 328 0.0054
283 FOETAL DEATH 28 0.0054
284 TROPONIN INCREASED 41 0.0054
285 FEELING DRUNK 40 0.0054
286 PERSONALITY CHANGE 50 0.0054
287 VERTIGO 328 0.0054
288 ANXIETY 1516 0.0053
289 PSYCHOMOTOR HYPERACTIVITY 88 0.0053
290 PANIC REACTION 38 0.0053
291 SCRATCH 55 0.0052
292 FAECAL INCONTINENCE 25 0.0052
293 DECREASED ACTIVITY 56 0.0052
294 MYOCARDITIS 59 0.0051
295 EPILEPSY 157 0.0051
296 DEPRESSION 1166 0.0051
297 SECRETION DISCHARGE 64 0.0051
298 ABNORMAL BEHAVIOUR 202 0.0051
299 SENSORY DISTURBANCE 81 0.0050
300 PARALYSIS 72 0.0050
301 TUBULOINTERSTITIAL NEPHRITIS 94 0.0050
302 RESPIRATORY ARREST 138 0.0050
303 HALLUCINATION 375 0.0050
304 MATERNAL DRUGS AFFECTING FOETUS 38 0.0050
305 SPEECH DISORDER 259 0.0049
306 HYPERCALCAEMIA 61 0.0049
307 SLEEP APNOEA SYNDROME 94 0.0049
308 ACUTE KIDNEY INJURY 753 0.0049
309 FLANK PAIN 46 0.0049
310 BLOOD MAGNESIUM DECREASED 42 0.0049
311 BENIGN PROSTATIC HYPERPLASIA 25 0.0048
312 ACUTE HEPATIC FAILURE 66 0.0048
313 MUSCLE TWITCHING 111 0.0048
314 ECCHYMOSIS 33 0.0048
315 HEPATITIS 123 0.0048
316 PULMONARY FIBROSIS 92 0.0048
317 NOCTURIA 58 0.0048
318 HYPOAESTHESIA ORAL 72 0.0048
319 HYPERTENSIVE CRISIS 53 0.0048
320 CARDIAC MURMUR 41 0.0047
321 JOINT DISLOCATION 50 0.0047
322 ACIDOSIS 36 0.0047
323 HYPERKALAEMIA 165 0.0047
324 BIPOLAR DISORDER 51 0.0047
325 VITAMIN D DECREASED 40 0.0047
326 CRYING 169 0.0046
327 MUSCLE TIGHTNESS 75 0.0046
328 PARAESTHESIA 721 0.0046
329 METABOLIC ACIDOSIS 146 0.0046
330 FEELING JITTERY 87 0.0046
331 LIGAMENT SPRAIN 45 0.0045
332 BLOOD CREATINE PHOSPHOKINASE INCREASED 131 0.0045
333 APPETITE DISORDER 30 0.0045
334 APNOEA 35 0.0045
335 BRAIN INJURY 45 0.0045
336 ACUTE RESPIRATORY FAILURE 86 0.0045
337 POOR QUALITY SLEEP 96 0.0045
338 HYPERCHOLESTEROLAEMIA 43 0.0044
339 HYPERTRIGLYCERIDAEMIA 26 0.0044
340 TINNITUS 204 0.0044
341 LETHARGY 254 0.0044
342 TRICUSPID VALVE INCOMPETENCE 35 0.0044
343 HYPOMAGNESAEMIA 61 0.0044
344 HYPOKALAEMIA 202 0.0044
345 MOOD ALTERED 119 0.0044
346 FACIAL PARALYSIS 37 0.0043
347 BALANCE DISORDER 375 0.0043
348 MENTAL IMPAIRMENT 105 0.0043
349 HEPATITIS B 26 0.0043
350 BLOOD SODIUM DECREASED 81 0.0043
351 NEUTROPHIL COUNT INCREASED 44 0.0043
352 HEPATIC STEATOSIS 80 0.0043
353 INITIAL INSOMNIA 44 0.0043
354 INGUINAL HERNIA 26 0.0043
355 HYPOGAMMAGLOBULINAEMIA 28 0.0043
356 INSOMNIA 1128 0.0042
357 AMNESIA 275 0.0042
358 GAMMA-GLUTAMYLTRANSFERASE INCREASED 93 0.0042
359 BRAIN OEDEMA 53 0.0042
360 WOUND 117 0.0042
361 ASTHENOPIA 23 0.0042
362 RENAL INJURY 124 0.0042
363 TOXIC SKIN ERUPTION 42 0.0042
364 NIGHT SWEATS 134 0.0042
365 SINUS CONGESTION 56 0.0041
366 SUBARACHNOID HAEMORRHAGE 42 0.0041
367 UNRESPONSIVE TO STIMULI 106 0.0041
368 BASAL CELL CARCINOMA 64 0.0041
369 ARTERIOSCLEROSIS CORONARY ARTERY 27 0.0041
370 SINUS BRADYCARDIA 39 0.0040
371 RESPIRATORY DISTRESS 111 0.0040
372 MIDDLE INSOMNIA 75 0.0040
373 ATRIOVENTRICULAR BLOCK 31 0.0040
374 HYPOGLYCAEMIA 194 0.0040
375 INTERVERTEBRAL DISC DEGENERATION 37 0.0040
376 SALIVARY HYPERSECRETION 40 0.0040
377 VENTRICULAR TACHYCARDIA 66 0.0040
378 FALL 1328 0.0040
379 SPINAL OSTEOARTHRITIS 35 0.0040
380 URINARY INCONTINENCE 118 0.0040
381 MEMORY IMPAIRMENT 547 0.0040
382 MITRAL VALVE INCOMPETENCE 45 0.0040
383 PALLOR 108 0.0040
384 TASTE DISORDER 80 0.0039
385 HAEMATOMA 102 0.0039
386 SLUGGISHNESS 40 0.0039
387 BODY TEMPERATURE INCREASED 80 0.0039
388 ENERGY INCREASED 23 0.0039
389 ANAL INCONTINENCE 35 0.0039
390 HAIR DISORDER 32 0.0039
391 APHTHOUS ULCER 30 0.0039
392 HEAD INJURY 122 0.0039
393 MICTURITION URGENCY 44 0.0038
394 TACHYPNOEA 52 0.0038
395 LEUKOCYTOSIS 69 0.0038
396 PHOTOPHOBIA 71 0.0038
397 MUSCULOSKELETAL STIFFNESS 330 0.0038
398 AGRANULOCYTOSIS 70 0.0038
399 ECONOMIC PROBLEM 57 0.0038
400 PRESCRIBED UNDERDOSE 75 0.0038
401 SPINAL COMPRESSION FRACTURE 31 0.0037
402 CARDIAC ARREST 309 0.0037
403 DRUG ABUSER 23 0.0037
404 ATRIOVENTRICULAR BLOCK COMPLETE 25 0.0037
405 HAEMATOCRIT DECREASED 74 0.0037
406 RENAL FAILURE 495 0.0037
407 PULMONARY CONGESTION 49 0.0037
408 PRODUCT ADMINISTRATION ERROR 75 0.0037
409 INCREASED TENDENCY TO BRUISE 34 0.0037
410 HYPERLIPIDAEMIA 44 0.0037
411 DRUG SCREEN POSITIVE 29 0.0037
412 PRESCRIBED OVERDOSE 71 0.0037
413 EJECTION FRACTION DECREASED 57 0.0037
414 HYPOTENSION 731 0.0036
415 MULTIPLE ORGAN DYSFUNCTION SYNDROME 103 0.0036
416 TOOTH ABSCESS 37 0.0036
417 STATUS EPILEPTICUS 41 0.0036
418 OXYGEN SATURATION DECREASED 204 0.0036
419 PRESYNCOPE 88 0.0036
420 NERVOUSNESS 186 0.0036
421 HIATUS HERNIA 46 0.0035
422 HOT FLUSH 267 0.0035
423 LIMB INJURY 96 0.0035
424 LACTIC ACIDOSIS 114 0.0035
425 DRUG WITHDRAWAL SYNDROME NEONATAL 52 0.0035
426 LUNG INFILTRATION 31 0.0035
427 TREATMENT NONCOMPLIANCE 192 0.0035
428 UPPER GASTROINTESTINAL HAEMORRHAGE 59 0.0035
429 RIB FRACTURE 72 0.0035
430 PALPITATIONS 408 0.0035
431 SWOLLEN TONGUE 108 0.0035
432 FEAR 93 0.0035
433 LOSS OF CONSCIOUSNESS 442 0.0034
434 SKIN PLAQUE 29 0.0034
435 VENTRICULAR FIBRILLATION 38 0.0034
436 CARDIOGENIC SHOCK 49 0.0034
437 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 164 0.0034
438 HAEMODYNAMIC INSTABILITY 26 0.0034
439 BACK INJURY 37 0.0034
440 MUSCLE INJURY 28 0.0034
441 HYPERBILIRUBINAEMIA 35 0.0034
442 HYPERGLYCAEMIA 123 0.0034
443 INTERNATIONAL NORMALISED RATIO INCREASED 96 0.0034
444 CONCUSSION 26 0.0034
445 TOOTH FRACTURE 37 0.0034
446 THERAPEUTIC PRODUCT EFFECT DECREASED 150 0.0033
447 COLD SWEAT 59 0.0033
448 HAEMORRHAGE INTRACRANIAL 50 0.0033
449 MYOSITIS 30 0.0033
450 FRUSTRATION TOLERANCE DECREASED 27 0.0033
451 BLOOD PRESSURE FLUCTUATION 80 0.0033
452 CHOLELITHIASIS 109 0.0033
453 EUPHORIC MOOD 34 0.0033
454 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 85 0.0033
455 SEIZURE 381 0.0033
456 COORDINATION ABNORMAL 46 0.0033
457 WOUND INFECTION 36 0.0033
458 PULMONARY OEDEMA 147 0.0033
459 INTENTIONAL PRODUCT MISUSE 287 0.0033
460 REBOUND EFFECT 37 0.0033
461 OVERDOSE 706 0.0033
462 SPUTUM DISCOLOURED 31 0.0033
463 OSTEOARTHRITIS 138 0.0033
464 ALANINE AMINOTRANSFERASE INCREASED 199 0.0032
465 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
466 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
467 LIVE BIRTH 27 0.0032
468 PULMONARY EMBOLISM 304 0.0032
469 ORAL CANDIDIASIS 42 0.0032
470 VITAMIN D DEFICIENCY 31 0.0032
471 POLYURIA 26 0.0032
472 PULMONARY ARTERIAL HYPERTENSION 46 0.0032
473 CARDIOMEGALY 39 0.0032
474 IMPAIRED HEALING 104 0.0032
475 DRUG ERUPTION 56 0.0032
476 WEIGHT INCREASED 705 0.0031
477 ULCER 50 0.0031
478 DRY MOUTH 255 0.0031
479 INTERSTITIAL LUNG DISEASE 152 0.0031
480 ISCHAEMIC STROKE 56 0.0031
481 LIVER INJURY 77 0.0031
482 SCIATICA 50 0.0031
483 MELAENA 69 0.0031
484 MENTAL DISORDER 136 0.0031
485 ASPARTATE AMINOTRANSFERASE INCREASED 166 0.0031
486 BLINDNESS UNILATERAL 44 0.0031
487 SUDDEN DEATH 33 0.0031
488 PANCREATITIS ACUTE 70 0.0031
489 MEDICATION ERROR 173 0.0031
490 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
491 RHINITIS 25 0.0031
492 HYPOXIA 109 0.0031
493 BLOOD CHOLESTEROL INCREASED 144 0.0031
494 DRUG INTOLERANCE 297 0.0031
495 EMPHYSEMA 31 0.0031
496 CEREBRAL HAEMORRHAGE 110 0.0031
497 CONDITION AGGRAVATED 932 0.0031
498 COAGULOPATHY 51 0.0031
499 HEPATOMEGALY 30 0.0030
500 ABNORMAL FAECES 25 0.0030
501 RESPIRATORY RATE INCREASED 27 0.0030
502 ESCHERICHIA INFECTION 25 0.0030
503 INCREASED APPETITE 58 0.0030
504 STAPHYLOCOCCAL INFECTION 100 0.0030
505 PHOTOSENSITIVITY REACTION 50 0.0030
506 HYPOAESTHESIA 453 0.0030
507 NECK PAIN 169 0.0030
508 RENAL CYST 24 0.0030
509 ASTHENIA 1131 0.0030
510 ATELECTASIS 29 0.0030
511 GASTROOESOPHAGEAL REFLUX DISEASE 241 0.0030
512 RESPIRATORY FAILURE 218 0.0030
513 NERVOUS SYSTEM DISORDER 93 0.0030
514 SKIN ULCER 77 0.0030
515 URINE OUTPUT DECREASED 26 0.0030
516 OSTEOPENIA 45 0.0030
517 MOVEMENT DISORDER 95 0.0030
518 LIVER FUNCTION TEST ABNORMAL 86 0.0030
519 DECUBITUS ULCER 24 0.0029
520 BLOOD TRIGLYCERIDES INCREASED 52 0.0029
521 MATERNAL EXPOSURE DURING PREGNANCY 262 0.0029
522 CIRCULATORY COLLAPSE 50 0.0029
523 HYPERSOMNIA 84 0.0029
524 EXPOSURE DURING PREGNANCY 182 0.0029
525 HYPERAESTHESIA 24 0.0029
526 DYSSTASIA 85 0.0029
527 CONTRAINDICATED PRODUCT ADMINISTERED 88 0.0029
528 HYPERTENSION 615 0.0029
529 SYNCOPE 290 0.0029
530 MUSCLE STRAIN 25 0.0029
531 HAEMATEMESIS 73 0.0029
532 BLOOD PRESSURE SYSTOLIC INCREASED 56 0.0029
533 ARTERIOSCLEROSIS 27 0.0029
534 LIP DRY 26 0.0029
535 PREMATURE BABY 86 0.0029
536 PERICARDITIS 48 0.0029
537 SKIN LACERATION 31 0.0028
538 FEELING COLD 79 0.0028
539 DECREASED APPETITE 659 0.0028
540 TARDIVE DYSKINESIA 80 0.0028
541 BLOOD THYROID STIMULATING HORMONE INCREASED 26 0.0028
542 TYPE 2 DIABETES MELLITUS 95 0.0028
543 DIZZINESS 1405 0.0028
544 PRODUCT SUBSTITUTION ISSUE 162 0.0028
545 DIPLOPIA 73 0.0028
546 INFLAMMATION 145 0.0028
547 BRAIN FOG 44 0.0028
548 CONTUSION 270 0.0028
549 POLLAKIURIA 116 0.0028
550 GAIT DISTURBANCE 532 0.0028
551 VISION BLURRED 381 0.0028
552 WEIGHT FLUCTUATION 29 0.0028
553 AUTOIMMUNE DISORDER 27 0.0028
554 TOXIC EPIDERMAL NECROLYSIS 42 0.0028
555 FOLLICULITIS 29 0.0028
556 SKIN INFECTION 31 0.0028
557 QUALITY OF LIFE DECREASED 37 0.0028
558 MIGRAINE 263 0.0028
559 DRY THROAT 28 0.0028
560 DEAFNESS 72 0.0028
561 THERAPY CESSATION 141 0.0027
562 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 195 0.0027
563 ADRENAL INSUFFICIENCY 33 0.0027
564 BLADDER DISORDER 27 0.0027
565 HAEMORRHOIDS 53 0.0027
566 TOOTH DISORDER 60 0.0027
567 VISUAL IMPAIRMENT 334 0.0027
568 ANURIA 23 0.0027
569 WRIST FRACTURE 32 0.0027
570 BLOOD PRESSURE ABNORMAL 53 0.0027
571 DEMENTIA 74 0.0026
572 JAUNDICE 71 0.0026
573 VOMITING 1239 0.0026
574 BLOOD POTASSIUM DECREASED 79 0.0026
575 HELICOBACTER INFECTION 27 0.0026
576 OSTEOPOROSIS 108 0.0026
577 HEPATIC FAILURE 79 0.0026
578 HAIR TEXTURE ABNORMAL 35 0.0026
579 DRUG EXPOSURE DURING PREGNANCY 89 0.0026
580 HIP FRACTURE 84 0.0026
581 PLATELET COUNT INCREASED 34 0.0026
582 C-REACTIVE PROTEIN INCREASED 94 0.0026
583 THIRST 46 0.0026
584 EOSINOPHILIA 45 0.0026
585 HEPATIC ENZYME INCREASED 175 0.0026
586 TRANSAMINASES INCREASED 57 0.0026
587 RASH MACULO-PAPULAR 57 0.0026
588 UPPER LIMB FRACTURE 51 0.0026
589 BURSITIS 31 0.0026
590 ARTHROPATHY 142 0.0026
591 VITREOUS FLOATERS 25 0.0025
592 MUSCLE SPASTICITY 31 0.0025
593 IRRITABLE BOWEL SYNDROME 54 0.0025
594 CHILLS 295 0.0025
595 BEDRIDDEN 33 0.0025
596 ORAL PAIN 56 0.0025
597 THERAPY PARTIAL RESPONDER 39 0.0025
598 DYSURIA 92 0.0025
599 GENERAL PHYSICAL HEALTH DETERIORATION 289 0.0025
600 EYELID OEDEMA 29 0.0025
601 HAIR COLOUR CHANGES 31 0.0025
602 BLOOD CALCIUM DECREASED 28 0.0025
603 HEART RATE INCREASED 246 0.0025
604 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 129 0.0025
605 GASTROENTERITIS 36 0.0025
606 TREATMENT FAILURE 204 0.0025
607 MYOCARDIAL ISCHAEMIA 28 0.0025
608 DIABETIC KETOACIDOSIS 59 0.0025
609 DENTAL CARIES 27 0.0024
610 CARDIOMYOPATHY 36 0.0024
611 FATIGUE 1894 0.0024
612 THROMBOCYTOPENIA 272 0.0024
613 GASTRITIS 64 0.0024
614 TOOTH INFECTION 32 0.0024
615 INTERVERTEBRAL DISC PROTRUSION 53 0.0024
616 BLOOD PRESSURE INCREASED 369 0.0024
617 FEELING ABNORMAL 578 0.0024
618 HYPOTHYROIDISM 77 0.0024
619 RESPIRATORY DISORDER 72 0.0024
620 ACCIDENTAL OVERDOSE 88 0.0024
621 RECTAL HAEMORRHAGE 103 0.0024
622 PETECHIAE 25 0.0024
623 HEADACHE 1499 0.0024
624 ANKLE FRACTURE 37 0.0024
625 MUSCLE SPASMS 438 0.0024
626 CONSTIPATION 520 0.0024
627 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
628 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
629 BLOOD URINE PRESENT 45 0.0024
630 BLOOD BILIRUBIN INCREASED 64 0.0024
631 SKIN DISORDER 79 0.0024
632 MUSCULOSKELETAL PAIN 124 0.0024
633 DIARRHOEA 1527 0.0024
634 URINARY TRACT INFECTION 403 0.0024
635 RASH PRURITIC 128 0.0024
636 INFLUENZA LIKE ILLNESS 194 0.0024
637 MUSCULAR WEAKNESS 267 0.0023
638 IMPAIRED WORK ABILITY 50 0.0023
639 PHARYNGITIS 29 0.0023
640 MADAROSIS 27 0.0023
641 TEMPERATURE INTOLERANCE 24 0.0023
642 MOUTH ULCERATION 49 0.0023
643 DEHYDRATION 310 0.0023
644 MYALGIA 393 0.0023
645 RED BLOOD CELL COUNT DECREASED 66 0.0023
646 SKIN DISCOLOURATION 106 0.0023
647 ANGIOEDEMA 102 0.0023
648 SPLENOMEGALY 27 0.0023
649 HEPATIC CIRRHOSIS 43 0.0023
650 OESOPHAGITIS 25 0.0023
651 GASTROINTESTINAL HAEMORRHAGE 191 0.0023
652 IMPAIRED GASTRIC EMPTYING 31 0.0023
653 INFLUENZA 253 0.0023
654 BLOOD CREATININE INCREASED 148 0.0023
655 EAR PAIN 44 0.0023
656 NASAL CONGESTION 133 0.0023
657 GASTRIC ULCER 43 0.0023
658 NAUSEA 1790 0.0023
659 HEAD DISCOMFORT 40 0.0023
660 PAIN IN JAW 64 0.0023
661 CHEST PAIN 418 0.0023
662 MOBILITY DECREASED 162 0.0023
663 ANAEMIA 430 0.0023
664 CORONARY ARTERY DISEASE 68 0.0022
665 BODY HEIGHT DECREASED 24 0.0022
666 GAIT INABILITY 75 0.0022
667 HEMIPARESIS 38 0.0022
668 BRONCHOSPASM 32 0.0022
669 PEMPHIGUS 28 0.0022
670 PANCREATITIS 118 0.0022
671 JOINT STIFFNESS 58 0.0022
672 CHOKING 43 0.0022
673 PERIPHERAL SWELLING 339 0.0022
674 GINGIVAL BLEEDING 30 0.0022
675 HAEMATURIA 75 0.0022
676 DYSPEPSIA 215 0.0022
677 WEIGHT DECREASED 609 0.0022
678 INFUSION RELATED REACTION 144 0.0022
679 HEART RATE IRREGULAR 49 0.0022
680 RENAL DISORDER 101 0.0022
681 HYPOCALCAEMIA 41 0.0022
682 DIVERTICULITIS 60 0.0022
683 EYE PAIN 122 0.0022
684 ABDOMINAL PAIN 502 0.0022
685 PRODUCT PRESCRIBING ISSUE 47 0.0022
686 DYSPHAGIA 204 0.0021
687 ABDOMINAL PAIN UPPER 442 0.0021
688 BONE DISORDER 39 0.0021
689 HEART RATE DECREASED 75 0.0021
690 LOWER LIMB FRACTURE 41 0.0021
691 LIMB DISCOMFORT 66 0.0021
692 JOINT SWELLING 257 0.0021
693 EPISTAXIS 159 0.0021
694 DYSPNOEA EXERTIONAL 80 0.0021
695 ADVERSE DRUG REACTION 190 0.0021
696 RETCHING 45 0.0021
697 DYSPNOEA 1193 0.0021
698 LUNG DISORDER 103 0.0021
699 PRODUCT PRESCRIBING ERROR 50 0.0021
700 DIABETES MELLITUS 160 0.0021
701 SHOCK 48 0.0021
702 BURNING SENSATION 146 0.0021
703 DRUG PRESCRIBING ERROR 40 0.0021
704 PULMONARY MASS 31 0.0021
705 DISABILITY 41 0.0021
706 SWELLING FACE 135 0.0021
707 RENAL IMPAIRMENT 174 0.0021
708 ARRHYTHMIA 98 0.0021
709 ARTHRALGIA 860 0.0021
710 PRODUCT DISPENSING ERROR 45 0.0021
711 PULMONARY HYPERTENSION 43 0.0021
712 ARTHRITIS 162 0.0021
713 GLOSSODYNIA 46 0.0021
714 CATARACT 122 0.0020
715 GLAUCOMA 39 0.0020
716 THERAPY NON-RESPONDER 91 0.0020
717 ABORTION SPONTANEOUS 81 0.0020
718 FRACTURE 38 0.0020
719 FEELING HOT 123 0.0020
720 FOOT FRACTURE 38 0.0020
721 LIVER FUNCTION TEST INCREASED 43 0.0020
722 BRONCHITIS 148 0.0020
723 MALAISE 876 0.0020
724 OEDEMA PERIPHERAL 243 0.0020
725 CHROMATURIA 45 0.0020
726 BLOOD TEST ABNORMAL 28 0.0020
727 EATING DISORDER 42 0.0020
728 BLOOD POTASSIUM INCREASED 32 0.0020
729 AGEUSIA 49 0.0020
730 RASH PAPULAR 44 0.0020
731 FREQUENT BOWEL MOVEMENTS 53 0.0020
732 LEUKOPENIA 98 0.0020
733 HAEMOGLOBIN DECREASED 201 0.0020
734 PRODUCT USE IN UNAPPROVED INDICATION 485 0.0020
735 BLOOD PRESSURE DECREASED 130 0.0020
736 TRANSIENT ISCHAEMIC ATTACK 66 0.0020
737 FUNGAL INFECTION 65 0.0019
738 ASTHMA 220 0.0019
739 PARAESTHESIA ORAL 28 0.0019
740 GASTROENTERITIS VIRAL 35 0.0019
741 EYE SWELLING 72 0.0019
742 CHOLECYSTITIS 23 0.0019
743 SINUSITIS 197 0.0019
744 PNEUMONIA 622 0.0019
745 BLOOD UREA INCREASED 32 0.0019
746 DRUG TOXICITY 26 0.0019
747 DEEP VEIN THROMBOSIS 124 0.0019
748 ABDOMINAL DISTENSION 198 0.0019
749 FIBROMYALGIA 46 0.0019
750 INJURY 133 0.0019
751 FULL BLOOD COUNT DECREASED 38 0.0019
752 HAEMATOCHEZIA 104 0.0019
753 CYSTITIS 60 0.0019
754 DEVICE RELATED INFECTION 29 0.0019
755 THYROID DISORDER 29 0.0019
756 STOMATITIS 114 0.0019
757 IMPAIRED QUALITY OF LIFE 27 0.0019
758 NEPHROLITHIASIS 86 0.0019
759 MUSCULOSKELETAL CHEST PAIN 29 0.0019
760 PSORIATIC ARTHROPATHY 76 0.0019
761 OROPHARYNGEAL PAIN 173 0.0019
762 ACTIVITIES OF DAILY LIVING IMPAIRED 37 0.0019
763 HUNGER 26 0.0019
764 ROAD TRAFFIC ACCIDENT 78 0.0019
765 JOINT RANGE OF MOTION DECREASED 25 0.0019
766 DRUG DEPENDENCE 299 0.0019
767 SPINAL FRACTURE 37 0.0018
768 BACK PAIN 426 0.0018
769 CONJUNCTIVITIS 34 0.0018
770 THERAPEUTIC RESPONSE DECREASED 111 0.0018
771 JOINT INJURY 39 0.0018
772 FEEDING DISORDER 37 0.0018
773 DRY EYE 91 0.0018
774 PAIN IN EXTREMITY 537 0.0018
775 COLITIS 69 0.0018
776 DISCOMFORT 111 0.0018
777 LYMPHOCYTE COUNT DECREASED 32 0.0018
778 PRURITUS GENERALISED 39 0.0018
779 PYREXIA 621 0.0018
780 DRUG ADMINISTRATION ERROR 55 0.0018
781 PLEURAL EFFUSION 109 0.0018
782 MASS 25 0.0018
783 RHEUMATOID ARTHRITIS 203 0.0018
784 BLISTER 100 0.0018
785 NEUTROPENIA 242 0.0018
786 DYSPHONIA 104 0.0018
787 ILL-DEFINED DISORDER 108 0.0018
788 BONE MARROW FAILURE 36 0.0018
789 SEPTIC SHOCK 77 0.0018
790 LYMPHOPENIA 25 0.0018
791 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
792 SEASONAL ALLERGY 25 0.0018
793 PNEUMOTHORAX 28 0.0018
794 GASTROINTESTINAL DISORDER 158 0.0018
795 THERAPEUTIC RESPONSE UNEXPECTED 79 0.0018
796 RHINORRHOEA 113 0.0017
797 SYSTEMIC LUPUS ERYTHEMATOSUS 62 0.0017
798 ABDOMINAL DISCOMFORT 293 0.0017
799 RENAL FAILURE ACUTE 74 0.0017
800 SNEEZING 39 0.0017
801 PROTEINURIA 33 0.0017
802 INTENTIONAL PRODUCT USE ISSUE 152 0.0017
803 ORAL DISCOMFORT 24 0.0017
804 EMOTIONAL DISTRESS 209 0.0017
805 SKIN LESION 47 0.0017
806 VIRAL INFECTION 57 0.0017
807 STEVENS-JOHNSON SYNDROME 38 0.0017
808 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
809 CARDIAC FAILURE 137 0.0017
810 FAECES DISCOLOURED 37 0.0017
811 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
812 ILLNESS 175 0.0017
813 PRODUCTIVE COUGH 81 0.0017
814 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 93 0.0017
815 GASTRIC DISORDER 58 0.0017
816 PAIN 1038 0.0017
817 RESPIRATORY TRACT INFECTION 44 0.0017
818 NEURALGIA 41 0.0017
819 MUSCULOSKELETAL DISCOMFORT 29 0.0017
820 INTENTIONAL DRUG MISUSE 35 0.0017
821 PRURITUS 641 0.0017
822 MENINGIOMA 26 0.0017
823 OEDEMA 90 0.0017
824 ANOSMIA 24 0.0017
825 HYPERTHYROIDISM 24 0.0017
826 NEUROTOXICITY 29 0.0017
827 CHEST DISCOMFORT 169 0.0016
828 BLOOD COUNT ABNORMAL 25 0.0016
829 SWELLING 154 0.0016
830 ANGINA PECTORIS 47 0.0016
831 INFECTION 237 0.0016
832 DRUG RESISTANCE 42 0.0016
833 MUSCULOSKELETAL DISORDER 31 0.0016
834 SEPSIS 180 0.0016
835 LUNG INFECTION 25 0.0016
836 CONVULSION 92 0.0016
837 DRUG INEFFECTIVE 2117 0.0016
838 LOCAL SWELLING 28 0.0016
839 TOOTHACHE 29 0.0016
840 OSTEOMYELITIS 29 0.0016
841 DRUG EFFECT INCOMPLETE 58 0.0016
842 OFF LABEL USE 1396 0.0016
843 CARDIAC FAILURE CONGESTIVE 128 0.0016
844 PANCYTOPENIA 89 0.0016
845 THROAT TIGHTNESS 43 0.0016
846 LOWER RESPIRATORY TRACT INFECTION 72 0.0016
847 KIDNEY INFECTION 31 0.0016
848 HYPOACUSIS 68 0.0016
849 EAR INFECTION 42 0.0016
850 OSTEONECROSIS OF JAW 39 0.0016
851 RESPIRATORY TRACT CONGESTION 25 0.0016
852 ATRIAL FIBRILLATION 153 0.0016
853 ALOPECIA 308 0.0016
854 WHEEZING 93 0.0016
855 KNEE ARTHROPLASTY 33 0.0016
856 SINUS DISORDER 31 0.0016
857 MULTIPLE SCLEROSIS RELAPSE 107 0.0016
858 ACUTE MYOCARDIAL INFARCTION 46 0.0016
859 DISEASE RECURRENCE 74 0.0016
860 EYE DISORDER 51 0.0015
861 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
862 ABASIA 38 0.0015
863 FLATULENCE 87 0.0015
864 RASH 667 0.0015
865 PERICARDIAL EFFUSION 35 0.0015
866 CLOSTRIDIUM DIFFICILE INFECTION 33 0.0015
867 MULTI-ORGAN FAILURE 26 0.0015
868 PRODUCT AVAILABILITY ISSUE 34 0.0015
869 NASOPHARYNGITIS 275 0.0015
870 HYPOPHAGIA 38 0.0015
871 PRODUCT DOSE OMISSION 97 0.0015
872 INTESTINAL OBSTRUCTION 56 0.0015
873 ORAL HERPES 29 0.0015
874 ACUTE MYELOID LEUKAEMIA 23 0.0015
875 FLUSHING 150 0.0015
876 FLUID RETENTION 75 0.0015
877 ECZEMA 77 0.0015
878 HAEMOPTYSIS 41 0.0015
879 CELLULITIS 73 0.0014
880 BACTERIAL INFECTION 27 0.0014
881 LIP SWELLING 48 0.0014
882 RASH MACULAR 50 0.0014
883 ASCITES 42 0.0014
884 DRUG DOSE OMISSION 235 0.0014
885 CANDIDA INFECTION 24 0.0014
886 SCAR 24 0.0014
887 RASH ERYTHEMATOUS 67 0.0014
888 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
889 DYSGEUSIA 104 0.0014
890 BONE PAIN 82 0.0014
891 COUGH 391 0.0014
892 GOUT 25 0.0014
893 LIVER DISORDER 61 0.0014
894 PSORIASIS 178 0.0014
895 VISUAL ACUITY REDUCED 45 0.0014
896 PLATELET COUNT DECREASED 144 0.0013
897 UNEVALUABLE EVENT 102 0.0013
898 HEPATOTOXICITY 30 0.0013
899 ERYTHEMA 276 0.0013
900 THROAT IRRITATION 60 0.0013
901 SKIN FISSURES 26 0.0013
902 WHITE BLOOD CELL COUNT DECREASED 144 0.0013
903 THERAPEUTIC RESPONSE SHORTENED 44 0.0013
904 URTICARIA 221 0.0013
905 SKIN EXFOLIATION 111 0.0013
906 ADVERSE EVENT 121 0.0013
907 EYE PRURITUS 44 0.0013
908 CARDIAC DISORDER 122 0.0013
909 HAEMORRHAGE 133 0.0013
910 LACRIMATION INCREASED 38 0.0013
911 INCORRECT PRODUCT ADMINISTRATION DURATION 27 0.0012
912 PRODUCT USE ISSUE 234 0.0012
913 THROMBOSIS 100 0.0012
914 FEBRILE NEUTROPENIA 82 0.0012
915 EXTRA DOSE ADMINISTERED 50 0.0012
916 FEMUR FRACTURE 38 0.0012
917 PNEUMONITIS 33 0.0012
918 NEUROPATHY PERIPHERAL 115 0.0012
919 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
920 HERPES ZOSTER 67 0.0012
921 HYPERSENSITIVITY 216 0.0012
922 LOCALISED INFECTION 28 0.0012
923 DERMATITIS 24 0.0011
924 DISEASE PROGRESSION 135 0.0011
925 DRUG EFFECT DECREASED 61 0.0011
926 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 204 0.0011
927 GYNAECOMASTIA 35 0.0011
928 LYMPHADENOPATHY 40 0.0011
929 PRODUCT QUALITY ISSUE 153 0.0011
930 INTENTIONAL DOSE OMISSION 32 0.0011
931 PHARMACEUTICAL PRODUCT COMPLAINT 29 0.0011
932 DEATH 958 0.0011
933 MUCOSAL INFLAMMATION 29 0.0011
934 CEREBRAL INFARCTION 27 0.0011
935 CEREBROVASCULAR ACCIDENT 184 0.0011
936 NEUTROPHIL COUNT DECREASED 44 0.0011
937 THERAPY INTERRUPTED 77 0.0011
938 OSTEONECROSIS 35 0.0011
939 CARDIOVASCULAR DISORDER 27 0.0011
940 COVID-19 186 0.0011
941 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
942 OCULAR HYPERAEMIA 50 0.0011
943 LABORATORY TEST ABNORMAL 31 0.0010
944 RASH GENERALISED 27 0.0010
945 INCORRECT DOSE ADMINISTERED 238 0.0010
946 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 74 0.0010
947 VAGINAL HAEMORRHAGE 45 0.0010
948 DEVICE DISLOCATION 45 0.0010
949 DRY SKIN 137 0.0010
950 NEOPLASM PROGRESSION 35 0.0010
951 MULTIPLE SCLEROSIS 48 0.0010
952 PAIN OF SKIN 27 0.0010
953 MYOCARDIAL INFARCTION 173 0.0010
954 SKIN BURNING SENSATION 71 0.0010
955 SURGERY 58 0.0010
956 ANAPHYLACTIC REACTION 53 0.0010
957 HEPATIC FUNCTION ABNORMAL 35 0.0009
958 PROCEDURAL PAIN 26 0.0009
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 34 0.0009
960 BLINDNESS 38 0.0009
961 DERMATITIS ATOPIC 49 0.0009
962 HOSPITALISATION 142 0.0009
963 PRODUCT DOSE OMISSION ISSUE 268 0.0009
964 ACNE 69 0.0009
965 EXPIRED PRODUCT ADMINISTERED 30 0.0009
966 BONE DENSITY DECREASED 28 0.0009
967 ANAPHYLACTIC SHOCK 23 0.0009
968 DEVICE BREAKAGE 36 0.0009
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 179 0.0009
970 COLITIS ULCERATIVE 39 0.0009
971 PLASMA CELL MYELOMA 34 0.0009
972 INJECTION SITE MASS 31 0.0008
973 INJECTION SITE REACTION 57 0.0008
974 MALIGNANT NEOPLASM PROGRESSION 82 0.0008
975 UNDERDOSE 58 0.0008
976 INJECTION SITE BRUISING 63 0.0008
977 BLOOD GLUCOSE INCREASED 147 0.0008
978 LUNG NEOPLASM MALIGNANT 31 0.0008
979 EYE IRRITATION 42 0.0007
980 BLOOD GLUCOSE DECREASED 33 0.0007
981 ACCIDENTAL EXPOSURE TO PRODUCT 65 0.0006
982 NO ADVERSE EVENT 114 0.0006
983 DEPENDENCE 34 0.0006
984 INJECTION SITE PRURITUS 41 0.0006
985 DEVICE MALFUNCTION 42 0.0006
986 INJECTION SITE HAEMORRHAGE 47 0.0006
987 DEVICE ISSUE 52 0.0006
988 NEOPLASM MALIGNANT 35 0.0005
989 INJECTION SITE ERYTHEMA 63 0.0005
990 BREAST CANCER 44 0.0005
991 INJECTION SITE PAIN 140 0.0005
992 INJECTION SITE SWELLING 32 0.0004